Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro J. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. https://www.ajmc.com/view/dec04-1992ps451-s461

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro J
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial fibrillation prevalence doubles with age
    Atrial fibrillation prevalence doubles with each decade of age—reaching close to 9% by age 80.  
  • Cost of AFib-related stroke in Medicare patients
    The incremental treatment costs associated with stroke in the year following diagnosis of atrial fibrillation are an estimated $7,907 per Medicare patient.  
  • Atrial fibrillation on death certificates
    In 2008, atrial fibrillation was mentioned on 99,294 death certificates in the U.S. and was the underlying cause of death in 15,383.  
  • AFib prevalence estimates
    Atrial fibrillation is the most common heart arrhythmia in the U.S. Often going undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans.  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.